Impact of Pilates Exercises on Diabetic Erectile Dysfunction.
PilatesDED2025
1 other identifier
interventional
60
1 country
1
Brief Summary
Erectile dysfunction (ED) has a prevalence of 52.5% in diabetic male patients, as described in a meta-analysis of 145 studies, including 88,577 men with type 1 and type 2 diabetes. In men, ED can cause sexual dissatisfaction and distress, unsatisfactory relationships, and marital tension
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2025
CompletedStudy Start
First participant enrolled
December 15, 2025
CompletedFirst Posted
Study publicly available on registry
December 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 22, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 23, 2026
CompletedJune 25, 2026
December 1, 2025
6 months
December 8, 2025
June 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
penile perfusion
Colour-coded duplex sonography (5-10 MHz probes) will be used for the evaluation of penile perfusion. Half ml of a vasoactive agent (trimix solution) will be injected into the corpus cavernosum. The systolic and diastolic velocities (cm/s) will be performed at 10 and 30 min for both cavernous artery. Re-dosing with 0.5 ml of trimax solution will be performed for patients who did not achieve adequate hardness. The highest values obtained will be recorded. The Doppler indices of the right and left cavernous arteries: peak systolic velocity (PSV)
Base line and after 12 weeks
Secondary Outcomes (1)
International Index of Erectile Function-5 (IIEF-5) scale.
Baseline and after 12 weeks
Study Arms (2)
Experimental
EXPERIMENTALActive comparator
ACTIVE COMPARATORInterventions
Participants will receive sildenafil citrate 25 mg orally once daily and sildenafil citrate 50 mg orally on demand, taken approximately 1 hour before sexual intercourse, throughout the study period.
Participants will attend an educational session conducted by a physiotherapist on pelvic floor anatomy, the physiology of erection, and the roles of the ischiocavernosus and bulbocavernosus muscles in erectile function. They will be instructed on proper pelvic floor muscle contraction by simulating the interruption of urine flow and performing maximal voluntary contractions. A home-based PFMT program will be prescribed. Exercises will initially be performed in the supine position with knees flexed and subsequently progressed to sitting or standing positions as tolerated. Participants will be instructed to perform PFMT twice daily (morning and evening), consisting of 15 short contractions (1 second each) and 15 sustained contractions (6-10 seconds each). Adherence will be monitored through a mobile messaging application, where participants will report completion of daily exercises and receive reminders when necessary.
Pilates protocol that will be used in the present study consisted of 11 different Pilates postures: Pilates Breathing, Spine Stretch, Swan, Shoulder Bridge, Hundreds, Double Leg Stretch, Footwork, Roll up, Single Leg Stretch, Leg Pull Back, Kick front and back. It will be performed thrice a week, with each session lasting 60 minutes, for 12 weeks, totaling 36 sessions. The progression of the exercises will be based on increasing the number of repetitions of the exercise, and variations in posture from beginner to intermediate and advanced, for each exercise. The movements will be repeated six to eight times each.
Eligibility Criteria
You may qualify if:
- Men aged 40-60 years.
- Married.
- Diagnosed with type 2 diabetes mellitus for \>5 years, with initial diagnosis confirmed by HbA1c \>6.5%.
- Arteriogenic erectile dysfunction (ED) of \>6 months' duration, confirmed by penile Doppler ultrasonography showing peak systolic velocity (PSV) of the cavernosal arteries \<25 cm/s.
- Body mass index (BMI) \<30 kg/m².
You may not qualify if:
- Poorly controlled diabetes mellitus (HbA1c \>9%).
- Neurogenic, venogenic, or psychogenic ED.
- Cardiac conditions contraindicating sexual activity.
- Neurological disorders or spinal cord injury.
- Alcohol abuse or illicit drug use.
- Chronic hematological disorders.
- Active genitourinary infection.
- Severe hypogonadism.
- History of radical prostatectomy, pelvic surgery, or pelvic trauma.
- Penile prosthesis implantation.
- Current or previous participation in a structured pelvic floor muscle training or sexual rehabilitation program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benha Universitylead
Study Sites (1)
Outpatient clinic, faculty of Physical Therapy, Benha university
Banhā, Benha, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcomes Assessor blinded This is a parallel group randomized controlled trial with two arms receiving different interventions.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Physical Therapy
Study Record Dates
First Submitted
December 8, 2025
First Posted
December 19, 2025
Study Start
December 15, 2025
Primary Completion
June 22, 2026
Study Completion
June 23, 2026
Last Updated
June 25, 2026
Record last verified: 2025-12